Life Stem Genetics LIFS announced today a strategic
collaborative agreement with American CryoStem Corporation,
CRYO. CRYO is a leading developer, marketer and global licensor
of patented adipose tissue-based cellular technologies for the
Regenerative and Personalized Medicine industries.
Adipose tissue is an anatomical term for loose connective tissue (fat)
composed of adipocytes (cells). It is used in LIFS stem cell procedures
and currently is extracted via liposuction each time a patient has a
treatment. This collaboration will give our physician's network the
ability to store a patient's adipose tissue for future regenerative
medicine applications after only one extraction process. In the absence
of future liposuction procedures, the patient's recovery time is
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in